ArticlePloS one2013

Identifying resistance mechanisms against five tyrosine kinase inhibitors targeting the ERBB/RAS pathway in 45 cancer cell lines.

Zsófia Pénzváltó et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.